Using low contrast CT for planning heart valve replacement
Official title: Dual Energy CT Decreased IV Contrast Dose Imaging for TAVR
Run by University of Maryland, Baltimore · NCT05758701 · Data updated 2026-11-12
This study is testing if using less contrast dye in special CT scans can help doctors plan heart valve replacement surgery while keeping patients safer and saving money.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 88 Years |
| Sex | All |
| Enrollment | 164 (estimated) |
| Sponsor | University of Maryland, Baltimore Academic / other |
| Locations | 1 site (Baltimore, Maryland) |
| Status | Recruiting |
| Started | September 19, 2023 |
| Main results expected | March 1, 2028 |
| Study ends | March 1, 2028 |
| Registry record updated | July 1, 2026 |
| Trial ID | NCT05758701 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients scheduled to receive a TAVR abdominal CT.
✕Probably not a fit
Patients who cannot undergo a CT scan or have a GFR less than 30 will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the use of low-dose iodinated contrast in dual energy CT scans for patients scheduled to undergo transcatheter aortic valve replacement (TAVR). The aim is to determine if this method can effectively assist in presurgical planning while reducing the risk of acute kidney injury and addressing the shortage of iodinated contrast agents. By utilizing monoenergetic reconstruction techniques, the study seeks to optimize imaging quality with a lower volume of contrast. This approach could lead to significant cost savings for healthcare facilities and improve patient safety.
Why it matters
Potential benefit: If successful, this study could enhance the safety and efficiency of TAVR procedures by minimizing contrast-related complications.
How similar studies have gone: Other studies have explored low-dose contrast methods, but this specific approach using dual energy CT for TAVR planning is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * scheduled to receive TAVR abdominal CT Exclusion Criteria: * cannot undergo CT scan * Allergy to intravenous contrast not controlled by steroids or benadryl * GFR\<30
Where it's running
-
University of Maryland Medical Center
Baltimore, Maryland, United States Recruiting
Study contacts
- Study coordinator: Vikas Kundra, M.D., Ph.D
- Email: vkundra@som.umaryland.edu
- Phone: 410-328-3477
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SYMmetric Valve expansion to reduce hypoattenuated leaflet thickening after balloon-expandable TAVI
This trial tests whether the Double-TAP post-dilatation strategy can reduce HALT and improve valve function in patients 70 or older undergoing balloon-expandable TAVI.
-
Low-dose Colchicine after TAVR to help prevent valve clots
This study tests whether taking a low dose of colchicine for 12 months after transcatheter aortic valve replacement can reduce valve thrombosis compared with standard care alone.
-
Transcatheter Mitral and Tricuspid Interventions and Cardiac MRI Registry
This study will collect imaging and clinical data from adults undergoing transcatheter mitral or tricuspid procedures to see how their heart structure and function change over time using MRI and advanced ultrasound.
-
Evaluation of the Point-Guard device during heart valve replacement
This study is testing a new device called Point-Guard to see if it can help prevent brain problems during heart valve replacement surgery.
-
Single versus Dual Perclose Device Closure for Large-Bore Femoral Access in TAVR
This will test whether using one Perclose device instead of two closes large-bore femoral access faster and with similar or fewer complications in people having transfemoral TAVR.
-
Assessing coronary artery disease in patients undergoing TAVI
This study is testing whether a non-invasive way to check for heart artery problems is better than the usual invasive method for patients with severe aortic stenosis who are getting a new heart valve.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.